1. Phase 1 study of combinatorial sorafenib, G‐CSF, and plerixafor treatment in relapsed/refractory, FLT3‐ITD‐mutated acute myelogenous leukemia patients. Issue 11 (19th August 2020) Authors: Borthakur, Gautam; Zeng, Zhihong; Cortes, Jorge E.; Chen, Hsiang‐Chun; Huang, Xuelin; Konopleva, Marina; Ravandi, Farhad; Kadia, Tapan; Patel, Keyur P.; Daver, Naval; Kelly, Mary A.; McQueen, Teresa; Wang, Ru‐Yiu; Kantarjian, Hagop; Andreeff, Michael Journal: American journal of hematology Issue: Volume 95:Issue 11(2020:Nov.) Page Start: 1296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗